DIPG
Clinical trials for DIPG explained in plain language.
Never miss a new study
Get alerted when new DIPG trials appear
Sign up with your email to follow new studies for DIPG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target deadly brain tumors in children
Disease control Recruiting nowThis study tests a new treatment called BCB-276 for children and young adults with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. BCB-276 is made from a patient's own immune cells, which are modified in a lab to recognize and attack the cancer. The tr…
Matched conditions: DIPG
Phase: PHASE2 • Sponsor: BrainChild Bio, Inc • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Promising combo targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis study is testing a combination of two drugs—a targeted radioactive drug (177Lu-DOTATATE) and a PARP inhibitor (olaparib)—in children and teens aged 3 to 18 with certain solid tumors that have come back or not responded to treatment. The goal is to see if the combination is s…
Matched conditions: DIPG
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC